Trials / Sponsors / Anne Beaven, MD
Anne Beaven, MD
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL PTCL, CTCL | Phase 1 | 2016-11-01 |
| Withdrawn | Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies Hematologic Malignancies | Phase 2 | 2015-05-01 |
| Terminated | Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Diffuse Large B-cell Lymphoma | Phase 2 | 2012-02-01 |
| Completed | IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma | Phase 1 | 2011-11-01 |